CALISA ACQUISITION Financials

ALISU

Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows CALISA ACQUISITION (ALISU) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI ALISU FY2025 2026-04-22

ALISU’s FY2025 economics are dominated by external funding, as $60.7M of financing covered cash needs and asset expansion.

The striking mix of net income of $245K and an operating loss of -$191K means reported profit did not come from the underlying revenue engine. That reading is reinforced by negative operating cash flow of -$287K, which shows the core business still consumed cash even as bottom-line earnings were positive.

The balance sheet is asset-heavy but thinly capitalized, with only $503K of equity supporting $61.0M of assets. That makes return on equity of 48.8% look denominator-driven rather than broad profitability, especially since ROA is only 0.4%.

The current ratio of 6.9x looks comfortable, but it rests on just $588K of current assets, so short-term liquidity is modest in absolute dollars. More important, a $60.0M investing outflow was essentially funded by outside capital, pointing to a business that is reshaping its asset base without internally generated cash.

Financial Health Signals

Financial Profile 33/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of CALISA ACQUISITION's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

CALISA ACQUISITION has an operating margin of -44.4%, meaning the company retains $-44 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses.

Leverage

CALISA ACQUISITION has elevated debt relative to equity (D/E of 120.30), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 0/100, reflecting increased financial risk.

Liquidity

100

With a current ratio of 6.91, CALISA ACQUISITION holds $6.91 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 100/100.

Returns

100

CALISA ACQUISITION earns a strong 48.8% return on equity (ROE), meaning it generates $49 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 100/100.

Earnings Quality Low Quality

-1.17x

For every $1 of reported earnings, CALISA ACQUISITION generates $-1.17 in operating cash flow (-$287K OCF vs $245K net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$429K

CALISA ACQUISITION generated $429K in revenue in fiscal year 2025.

EBITDA

N/A

Net Income

$245K

CALISA ACQUISITION reported $245K in net income in fiscal year 2025.

EPS (Diluted)

N/A

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

$459K

CALISA ACQUISITION held $459K in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

CALISA ACQUISITION had 8M shares outstanding in fiscal year 2025.

Margins & Returns

Gross Margin

N/A

Operating Margin

-44.4%

CALISA ACQUISITION's operating margin was -44.4% in fiscal year 2025, reflecting core business profitability.

Net Margin

57.2%

CALISA ACQUISITION's net profit margin was 57.2% in fiscal year 2025, showing the share of revenue converted to profit.

Return on Equity

48.8%

CALISA ACQUISITION's ROE was 48.8% in fiscal year 2025, measuring profit generated per dollar of shareholder equity.

Capital Allocation

R&D Spending

N/A

Share Buybacks

N/A

Capital Expenditures

N/A

ALISU Income Statement

Metric	FY25
Revenue	$429K
Cost of Revenue	N/A
Gross Profit	N/A
R&D Expenses	N/A
SG&A Expenses	N/A
Operating Income	-$191K
Interest Expense	N/A
Income Tax	N/A
Net Income	$245K
EPS (Diluted)	N/A

Metric	Q4'25	Q3'25	Q4'24	Q3'24	Q2'24
Revenue	N/A	N/A	N/A	N/A	N/A
Cost of Revenue	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	N/A	N/A	N/A	N/A	N/A
Operating Income	N/A	-$62K	N/A	-$21K	N/A
Interest Expense	N/A	N/A	N/A	N/A	N/A
Income Tax	N/A	N/A	N/A	N/A	N/A
Net Income	N/A	-$62K	N/A	-$21K+65.0%	-$59K
EPS (Diluted)	N/A	$-0.03	N/A	$-0.01	N/A

ALISU Balance Sheet

Metric	FY25
Total Assets	$61.0M
Current Assets	$588K
Cash & Equivalents	$459K
Inventory	N/A
Accounts Receivable	N/A
Goodwill	N/A
Total Liabilities	$60.5M
Current Liabilities	$85K
Long-Term Debt	N/A
Total Equity	$503K
Retained Earnings	$166K

Metric	Q4'25	Q3'25	Q4'24	Q3'24	Q2'24
Total Assets	$61.0M+2680.6%	$2.2M+894.6%	$221K	N/A	N/A
Current Assets	$588K-73.2%	$2.2M+894.6%	$221K	N/A	N/A
Cash & Equivalents	$459K-75.9%	$1.9M+127807.7%	$1K	N/A	N/A
Inventory	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$60.5M+2705.5%	$2.2M+1366.8%	$147K	N/A	N/A
Current Liabilities	$85K-96.1%	$2.2M+1366.8%	$147K	N/A	N/A
Long-Term Debt	N/A	N/A	N/A	N/A	N/A
Total Equity	$503K+1244.1%	$37K-49.1%	$74K+0.1%	$74K-21.9%	$94K
Retained Earnings	$166K+201.3%	-$164K-106.4%	-$79K	N/A	N/A

ALISU Cash Flow Statement

Metric	FY25
Operating Cash Flow	-$287K
Capital Expenditures	N/A
Free Cash Flow	N/A
Investing Cash Flow	-$60.0M
Financing Cash Flow	$60.7M
Dividends Paid	N/A
Share Buybacks	N/A

Metric	Q4'25	Q3'25	Q4'24	Q3'24	Q2'24
Operating Cash Flow	-$163K	N/A	N/A	N/A	N/A
Capital Expenditures	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	N/A	N/A	N/A	N/A	N/A
Financing Cash Flow	$58.7M	N/A	$0	N/A	N/A
Dividends Paid	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A

ALISU Financial Ratios

Metric	FY25
Gross Margin	N/A
Operating Margin	-44.4%
Net Margin	57.2%
Return on Equity	48.8%
Return on Assets	0.4%
Current Ratio	6.91
Debt-to-Equity	120.30
FCF Margin	N/A

Metric	Q4'25	Q3'25	Q4'24	Q3'24	Q2'24
Gross Margin	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A
Net Margin	N/A	N/A	N/A	N/A	N/A
Return on Equity	N/A	-165.1%	N/A	-28.0%+34.5pp	-62.5%
Return on Assets	N/A	-2.8%	N/A	N/A	N/A
Current Ratio	6.91+5.9	1.02-0.5	1.50	N/A	N/A
Debt-to-Equity	120.30+62.7	57.63+55.6	2.00	N/A	N/A
FCF Margin	N/A	N/A	N/A	N/A	N/A

Frequently Asked Questions

What is CALISA ACQUISITION's annual revenue?

CALISA ACQUISITION (ALISU) reported $429K in total revenue for fiscal year 2025. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Is CALISA ACQUISITION profitable?

Yes, CALISA ACQUISITION (ALISU) reported a net income of $245K in fiscal year 2025, with a net profit margin of 57.2%.

What is CALISA ACQUISITION's operating margin?

CALISA ACQUISITION (ALISU) had an operating margin of -44.4% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is CALISA ACQUISITION's net profit margin?

CALISA ACQUISITION (ALISU) had a net profit margin of 57.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is CALISA ACQUISITION's return on equity (ROE)?

CALISA ACQUISITION (ALISU) has a return on equity of 48.8% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is CALISA ACQUISITION's operating cash flow?

CALISA ACQUISITION (ALISU) generated -$287K in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are CALISA ACQUISITION's total assets?

CALISA ACQUISITION (ALISU) had $61.0M in total assets as of fiscal year 2025, including both current and long-term assets.

How many shares does CALISA ACQUISITION have outstanding?

CALISA ACQUISITION (ALISU) had 8M shares outstanding as of fiscal year 2025.

What is CALISA ACQUISITION's current ratio?

CALISA ACQUISITION (ALISU) had a current ratio of 6.91 as of fiscal year 2025, which is generally considered healthy.

What is CALISA ACQUISITION's debt-to-equity ratio?

CALISA ACQUISITION (ALISU) had a debt-to-equity ratio of 120.30 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is CALISA ACQUISITION's return on assets (ROA)?

CALISA ACQUISITION (ALISU) had a return on assets of 0.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is CALISA ACQUISITION's cash runway?

Based on fiscal year 2025 data, CALISA ACQUISITION (ALISU) had $459K in cash against an annual operating cash burn of $287K. This gives an estimated cash runway of approximately 19 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Are CALISA ACQUISITION's earnings high quality?

CALISA ACQUISITION (ALISU) has an earnings quality ratio of -1.17x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is CALISA ACQUISITION?

CALISA ACQUISITION (ALISU) scores 33 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.